Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months
By: theblockbeats.news|2025/09/02 13:52:27
BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.
WEEX causa sensación en BlockchainRIO 2025
Escenario global de WEEX: De Singapur a Dubái
También te puede interesar
Compartir
Ganadores
Últimas noticias sobre criptomonedas
16:24
In the past 4 hours, the entire network has seen $320 million in liquidations, with most of them coming from long positions.
16:22
EU Law Enforcement Agency Seizes Coin Mixing Service Platform Cryptomixer
16:20
US Stock Strategy (MSTR) Plunges Over 10% During Trading
15:53
Bloomberg: FDUSD Issuer First Digital Plans to Go Public on the US Stock Market Through SPAC Merger
15:50
「Buddy」 once again made a deposit to Hyperliquid of approximately 250,000 U to top up his ETH long position.
Leer más
Comunitario
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]